The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Therapeutic Protein-Global Market Insights and Sales Trends 2024
Synopsis
Therapeutic proteins are the engineered proteins in the laboratory intended for pharmaceutical use.
The global Therapeutic Protein market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Therapeutic Protein in various end use industries. The expanding demands from the Pharmaceutical Companies, Healthcare Service Providers, Research Organizations and Academic Research Institutes, are propelling Therapeutic Protein market. Monoclonal Antibodies, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Erythropoietin segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Therapeutic Protein, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Therapeutic Protein market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Therapeutic Protein market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Therapeutic Protein sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Therapeutic Protein covered in this report include Amgen, Abbott Laboratories, AstraZeneca, Baxter International, Boehringer Ingelheim, Chugai Pharmaceutical, Diasome Pharmaceuticals, Eli Lilly and GeneScience Pharmaceuticals, etc.
The global Therapeutic Protein market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Amgen
Abbott Laboratories
AstraZeneca
Baxter International
Boehringer Ingelheim
Chugai Pharmaceutical
Diasome Pharmaceuticals
Eli Lilly
GeneScience Pharmaceuticals
Generex Biotechnology
Genentech
Global Therapeutic Protein market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Therapeutic Protein market, Segment by Type:
Monoclonal Antibodies
Erythropoietin
Insulin
Interferon
Human Growth Hormone
Follicle Stimulating Hormone
Blood Clotting Factors
Global Therapeutic Protein market, by Application
Pharmaceutical Companies
Healthcare Service Providers
Research Organizations
Academic Research Institutes
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Therapeutic Protein manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Therapeutic Protein in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Therapeutic proteins are the engineered proteins in the laboratory intended for pharmaceutical use.
The global Therapeutic Protein market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Therapeutic Protein in various end use industries. The expanding demands from the Pharmaceutical Companies, Healthcare Service Providers, Research Organizations and Academic Research Institutes, are propelling Therapeutic Protein market. Monoclonal Antibodies, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Erythropoietin segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Therapeutic Protein, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Therapeutic Protein market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Therapeutic Protein market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Therapeutic Protein sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Therapeutic Protein covered in this report include Amgen, Abbott Laboratories, AstraZeneca, Baxter International, Boehringer Ingelheim, Chugai Pharmaceutical, Diasome Pharmaceuticals, Eli Lilly and GeneScience Pharmaceuticals, etc.
The global Therapeutic Protein market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Amgen
Abbott Laboratories
AstraZeneca
Baxter International
Boehringer Ingelheim
Chugai Pharmaceutical
Diasome Pharmaceuticals
Eli Lilly
GeneScience Pharmaceuticals
Generex Biotechnology
Genentech
Global Therapeutic Protein market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Therapeutic Protein market, Segment by Type:
Monoclonal Antibodies
Erythropoietin
Insulin
Interferon
Human Growth Hormone
Follicle Stimulating Hormone
Blood Clotting Factors
Global Therapeutic Protein market, by Application
Pharmaceutical Companies
Healthcare Service Providers
Research Organizations
Academic Research Institutes
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Therapeutic Protein manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Therapeutic Protein in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Therapeutic Protein Market Overview
1.1 Therapeutic Protein Product Overview
1.2 Therapeutic Protein Market Segment by Type
1.2.1 Monoclonal Antibodies
1.2.2 Erythropoietin
1.2.3 Insulin
1.2.4 Interferon
1.2.5 Human Growth Hormone
1.2.6 Follicle Stimulating Hormone
1.2.7 Blood Clotting Factors
1.3 Global Therapeutic Protein Market Size by Type
1.3.1 Global Therapeutic Protein Market Size Overview by Type (2018-2029)
1.3.2 Global Therapeutic Protein Historic Market Size Review by Type (2018-2023)
1.3.3 Global Therapeutic Protein Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Therapeutic Protein Sales Breakdown by Type (2018-2023)
1.4.2 Europe Therapeutic Protein Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Therapeutic Protein Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Therapeutic Protein Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Therapeutic Protein Sales Breakdown by Type (2018-2023)
2 Global Therapeutic Protein Market Competition by Company
2.1 Global Top Players by Therapeutic Protein Sales (2018-2023)
2.2 Global Top Players by Therapeutic Protein Revenue (2018-2023)
2.3 Global Top Players by Therapeutic Protein Price (2018-2023)
2.4 Global Top Manufacturers Therapeutic Protein Manufacturing Base Distribution, Sales Area, Product Type
2.5 Therapeutic Protein Market Competitive Situation and Trends
2.5.1 Therapeutic Protein Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Therapeutic Protein Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Therapeutic Protein as of 2022)
2.7 Date of Key Manufacturers Enter into Therapeutic Protein Market
2.8 Key Manufacturers Therapeutic Protein Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Therapeutic Protein Status and Outlook by Region
3.1 Global Therapeutic Protein Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Therapeutic Protein Historic Market Size by Region
3.2.1 Global Therapeutic Protein Sales in Volume by Region (2018-2023)
3.2.2 Global Therapeutic Protein Sales in Value by Region (2018-2023)
3.2.3 Global Therapeutic Protein Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Therapeutic Protein Forecasted Market Size by Region
3.3.1 Global Therapeutic Protein Sales in Volume by Region (2024-2029)
3.3.2 Global Therapeutic Protein Sales in Value by Region (2024-2029)
3.3.3 Global Therapeutic Protein Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Therapeutic Protein by Application
4.1 Therapeutic Protein Market Segment by Application
4.1.1 Pharmaceutical Companies
4.1.2 Healthcare Service Providers
4.1.3 Research Organizations
4.1.4 Academic Research Institutes
4.2 Global Therapeutic Protein Market Size by Application
4.2.1 Global Therapeutic Protein Market Size Overview by Application (2018-2029)
4.2.2 Global Therapeutic Protein Historic Market Size Review by Application (2018-2023)
4.2.3 Global Therapeutic Protein Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Therapeutic Protein Sales Breakdown by Application (2018-2023)
4.3.2 Europe Therapeutic Protein Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Therapeutic Protein Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Therapeutic Protein Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Therapeutic Protein Sales Breakdown by Application (2018-2023)
5 North America Therapeutic Protein by Country
5.1 North America Therapeutic Protein Historic Market Size by Country
5.1.1 North America Therapeutic Protein Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Therapeutic Protein Sales in Volume by Country (2018-2023)
5.1.3 North America Therapeutic Protein Sales in Value by Country (2018-2023)
5.2 North America Therapeutic Protein Forecasted Market Size by Country
5.2.1 North America Therapeutic Protein Sales in Volume by Country (2024-2029)
5.2.2 North America Therapeutic Protein Sales in Value by Country (2024-2029)
6 Europe Therapeutic Protein by Country
6.1 Europe Therapeutic Protein Historic Market Size by Country
6.1.1 Europe Therapeutic Protein Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Therapeutic Protein Sales in Volume by Country (2018-2023)
6.1.3 Europe Therapeutic Protein Sales in Value by Country (2018-2023)
6.2 Europe Therapeutic Protein Forecasted Market Size by Country
6.2.1 Europe Therapeutic Protein Sales in Volume by Country (2024-2029)
6.2.2 Europe Therapeutic Protein Sales in Value by Country (2024-2029)
7 Asia-Pacific Therapeutic Protein by Region
7.1 Asia-Pacific Therapeutic Protein Historic Market Size by Region
7.1.1 Asia-Pacific Therapeutic Protein Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Therapeutic Protein Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Therapeutic Protein Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Therapeutic Protein Forecasted Market Size by Region
7.2.1 Asia-Pacific Therapeutic Protein Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Therapeutic Protein Sales in Value by Region (2024-2029)
8 Latin America Therapeutic Protein by Country
8.1 Latin America Therapeutic Protein Historic Market Size by Country
8.1.1 Latin America Therapeutic Protein Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Therapeutic Protein Sales in Volume by Country (2018-2023)
8.1.3 Latin America Therapeutic Protein Sales in Value by Country (2018-2023)
8.2 Latin America Therapeutic Protein Forecasted Market Size by Country
8.2.1 Latin America Therapeutic Protein Sales in Volume by Country (2024-2029)
8.2.2 Latin America Therapeutic Protein Sales in Value by Country (2024-2029)
9 Middle East and Africa Therapeutic Protein by Country
9.1 Middle East and Africa Therapeutic Protein Historic Market Size by Country
9.1.1 Middle East and Africa Therapeutic Protein Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Therapeutic Protein Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Therapeutic Protein Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Therapeutic Protein Forecasted Market Size by Country
9.2.1 Middle East and Africa Therapeutic Protein Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Therapeutic Protein Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Amgen
10.1.1 Amgen Company Information
10.1.2 Amgen Introduction and Business Overview
10.1.3 Amgen Therapeutic Protein Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Amgen Therapeutic Protein Products Offered
10.1.5 Amgen Recent Development
10.2 Abbott Laboratories
10.2.1 Abbott Laboratories Company Information
10.2.2 Abbott Laboratories Introduction and Business Overview
10.2.3 Abbott Laboratories Therapeutic Protein Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Abbott Laboratories Therapeutic Protein Products Offered
10.2.5 Abbott Laboratories Recent Development
10.3 AstraZeneca
10.3.1 AstraZeneca Company Information
10.3.2 AstraZeneca Introduction and Business Overview
10.3.3 AstraZeneca Therapeutic Protein Sales, Revenue and Gross Margin (2018-2023)
10.3.4 AstraZeneca Therapeutic Protein Products Offered
10.3.5 AstraZeneca Recent Development
10.4 Baxter International
10.4.1 Baxter International Company Information
10.4.2 Baxter International Introduction and Business Overview
10.4.3 Baxter International Therapeutic Protein Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Baxter International Therapeutic Protein Products Offered
10.4.5 Baxter International Recent Development
10.5 Boehringer Ingelheim
10.5.1 Boehringer Ingelheim Company Information
10.5.2 Boehringer Ingelheim Introduction and Business Overview
10.5.3 Boehringer Ingelheim Therapeutic Protein Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Boehringer Ingelheim Therapeutic Protein Products Offered
10.5.5 Boehringer Ingelheim Recent Development
10.6 Chugai Pharmaceutical
10.6.1 Chugai Pharmaceutical Company Information
10.6.2 Chugai Pharmaceutical Introduction and Business Overview
10.6.3 Chugai Pharmaceutical Therapeutic Protein Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Chugai Pharmaceutical Therapeutic Protein Products Offered
10.6.5 Chugai Pharmaceutical Recent Development
10.7 Diasome Pharmaceuticals
10.7.1 Diasome Pharmaceuticals Company Information
10.7.2 Diasome Pharmaceuticals Introduction and Business Overview
10.7.3 Diasome Pharmaceuticals Therapeutic Protein Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Diasome Pharmaceuticals Therapeutic Protein Products Offered
10.7.5 Diasome Pharmaceuticals Recent Development
10.8 Eli Lilly
10.8.1 Eli Lilly Company Information
10.8.2 Eli Lilly Introduction and Business Overview
10.8.3 Eli Lilly Therapeutic Protein Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Eli Lilly Therapeutic Protein Products Offered
10.8.5 Eli Lilly Recent Development
10.9 GeneScience Pharmaceuticals
10.9.1 GeneScience Pharmaceuticals Company Information
10.9.2 GeneScience Pharmaceuticals Introduction and Business Overview
10.9.3 GeneScience Pharmaceuticals Therapeutic Protein Sales, Revenue and Gross Margin (2018-2023)
10.9.4 GeneScience Pharmaceuticals Therapeutic Protein Products Offered
10.9.5 GeneScience Pharmaceuticals Recent Development
10.10 Generex Biotechnology
10.10.1 Generex Biotechnology Company Information
10.10.2 Generex Biotechnology Introduction and Business Overview
10.10.3 Generex Biotechnology Therapeutic Protein Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Generex Biotechnology Therapeutic Protein Products Offered
10.10.5 Generex Biotechnology Recent Development
10.11 Genentech
10.11.1 Genentech Company Information
10.11.2 Genentech Introduction and Business Overview
10.11.3 Genentech Therapeutic Protein Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Genentech Therapeutic Protein Products Offered
10.11.5 Genentech Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Therapeutic Protein Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Therapeutic Protein Industrial Chain Analysis
11.4 Therapeutic Protein Market Dynamics
11.4.1 Therapeutic Protein Industry Trends
11.4.2 Therapeutic Protein Market Drivers
11.4.3 Therapeutic Protein Market Challenges
11.4.4 Therapeutic Protein Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Therapeutic Protein Distributors
12.3 Therapeutic Protein Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
